Dactinomycin 0.50 mg

DACILON 0.5mg is an injectable medication that contains 0.50mg of Dactinomycin as the active ingredient. It is commonly used in the treatment of various types of cancer, including Wilms' tumor, Ewing's sarcoma, rhabdomyosarcoma, and gestational trophoblastic neoplasia. It works by interfering with the growth and spread of cancer cells in the body. DACILON 0.5mg may be used alone or in combination with other anticancer drugs or treatment modalities as prescribed by the healthcare professional.

This medication is given by injection into a vein or a muscle by a healthcare professional. The dosage and frequency of administration are determined by the healthcare provider based on several factors including the type and stage of cancer being treated, overall health, and response to treatment.

Allopathic

The contents and information provided here are solely intended to provide a general overview of the products and medicines and must be used for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. The information contained herein should not be used as a substitute for the advice of a qualified physician. For all queries or doubts related to your medical condition, we highly recommend that you consult your registered medical practitioner.